澳优(01717.HK)一季度经调整纯利增近九成自家品牌业务保持稳中向好
格隆汇5月15日丨格隆汇获悉,澳优(01717.HK)5月14日披露2019年一季度业绩,报告期内,集团实现收入15.19亿元人民币(下同),同比增长29.0%;毛利7.48亿元,同比增长37.1%;毛利率上升2.9个百分点至49.2%;经调整公司权益拥有人应占利润1.95亿元,同比增长87.2%;经调整 EBITDA 2.66亿元,同比增长57.4%。
根据披露,今年第一季度,作为澳优的核心业务分部,自家品牌配方牛奶粉(尤其是盈利能力较高的海普诺凯荷致、能立多、淳璀 及悠蓝 等产品)及羊奶粉(佳贝艾特 )业务的表现继续稳中向好,收入分别增长21.1%及47.2%至5.67亿元及6.83亿元。
据了解,为达成公司的愿景,澳优在去年采取了一系列的战略行动。去年5月份,澳优完成海普诺凯集团收购事项,自此,海普诺凯集团成为公司的全资附属公司,与集团产生更大协同效益;去年6月份,澳优完成第二次Ozfarm收购事项,自此,Ozfarm成为公司的全资附属公司,进一步扩充了集团的市场。
此外,在去年12月份,澳优收购Nutrition Care Pharmaceuticals Pty Ltd余下25%股权以拓展营养品业务;及收购Ausnutrition Care Pty Ltd余下30%股权,以更有效地与集团婴幼儿配方奶粉的生产整合。
根据在去年初生效的中国新配方注册规定,中国所有婴幼儿配方系列必须向市场监管总局注册。于公告日期,澳优已向市场监管总局注册旗下合共15个系列的婴幼儿配方,其中3个系列新注册配方在今年3月下旬完成注册。董事会相信,新注册配方完成注册后将进一步充实产品组合,巩固集团的市场地位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.